Overview of WHO Public Assessment Report (WHOPAR)

HA527 - Efavirenz/Emtricitabine/Tenofovir disoproxil fumarate - 600mg/200mg/300mg - Film-coated tablets - Sun Pharmaceutical Industries Limited -
India

Part 1 – Abstract
Part 2a – All accepted presentations
Part 2b - Visual appearance of the product
Part 3 – Patient Information Leaflet
Part 4 – Summary of Product Characteristics
Part 5 – Label
Part 6 – Discussion (status at the time of prequalification)
Part 7 – Steps before Prequalification
Part 8 – Steps following Prequalification (from 01 March 2014, only changes to the published information are included)